Veronica Cottam

94-100 Mallett Street
Camperdown, NSW 2050, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model.

Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model.

Journal: Acta neuropathologica communications

Published: March 23, 2025

Imaging Copper Levels during Life in the Brain and beyond Using a Fluorescent Copper Sensor with Multimodal Capacity.

Imaging Copper Levels during Life in the Brain and beyond Using a Fluorescent Copper Sensor with Multimodal Capacity.

Journal: Chemical & biomedical imaging

Published: March 22, 2025

Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model.

Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model.

Journal: Acta neuropathologica

Published: October 30, 2024

Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu2+ in the Brain.

Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu2+ in the Brain.

Journal: ACS sensors

Published: May 24, 2024

Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord.

Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord.

Journal: Brain : a journal of neurology

Published: December 14, 2021

Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease.

Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease.

Journal: Brain pathology (Zurich, Switzerland)

Published: December 09, 2018

Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson's disease brain.

Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson's disease brain.

Journal: Acta neuropathologica

Published: December 06, 2016

Copper pathology in vulnerable brain regions in Parkinson's disease.

Copper pathology in vulnerable brain regions in Parkinson's disease.

Journal: Neurobiology of aging

Published: April 15, 2013

Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra.

Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: October 20, 2012

Localization of copper and copper transporters in the human brain.

Localization of copper and copper transporters in the human brain.

Journal: Metallomics : integrated biometal science

Published: October 19, 2012

Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease.

Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease.

Journal: Neurobiology of aging

Published: March 22, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026